Similar Items: Comment on ‘A Prospective Evaluation of Glucagon Stimulation Test Safety in Adults With Chronic Moderate‐to‐Severe Traumatic Brain Injury’
- A Prospective Evaluation of Glucagon Stimulation Test Safety in Adults With Chronic Moderate‐to‐Severe Traumatic Brain Injury
- Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
- Comment on ‘Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Centre, Prospective, Observational Study (REVISE Study)’
- Endogenous Glucagon-Like Peptide-1 as a Potential Mediator of the Resolution of Diabetic Kidney Disease following Roux en Y Gastric Bypass: Evidence and Perspectives
- Comment on ‘Oxidative Stress‐Induced Expression Levels of PXDN and NF‐κB in Type 2 Diabetic Patients With Nephropathy’
- Early predictors of 6-month thyroid-stimulating antibody levels after radioactive iodine therapy for Graves' disease: implications for pregnancy planning